← Open Payments lookup

ADAM TRAN: Open Payments

NPI 1700591484 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,738 in 174 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,655 · 2025 $4,738

Food & beverage: $4,727Education: $11
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc26$932
ABBVIE INC.25$551
Vanda Pharmaceuticals Inc.17$533
Neurocrine BioSciences, Inc.14$511
Otsuka America Pharmaceutical, Inc.13$437
Teva Pharmaceuticals USA, Inc.16$381
E.R. Squibb & Sons, L.L.C.10$305
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$240
Axsome Therapeutics, Inc.9$199
Alkermes, Inc.10$168

Products named: VRAYLAR, INGREZZA, SPRAVATO, FANAPT, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, COBENFY.

Industry payments across CA — which companies pay providers there.